Barclays Upgrades Arcturus Therapeutics (ARCT) to Equalweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. HD
9. BJ
10. BABA

November 2, 2022 7:17 AM EDT
Get Alerts ARCT Hot Sheet
Price: $13.45 +22.38%

Rating Summary:
    13 Buy, 5 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE

Barclays analyst Gena Wang upgraded Arcturus Therapeutics (NASDAQ: ARCT) from Underweight to Equalweight with a price target of $25.00 (from $16.00).


For an analyst ratings summary and ratings history on Arcturus Therapeutics click here. For more ratings news on Arcturus Therapeutics click here.


Shares of Arcturus Therapeutics closed at $18.28 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades